Dongyang Liu

5.7k citations
183 papers · 3.9k indexed · 1 hit paper · h-index 24

Dongyang Liu

165 papers receiving 3.8k citations

Hit Papers

In Vitro Antiviral Activity and Projection of Optimized D...1.9k202020262022202450010001.5k

Peers

Dongyang Liu
Comparison fields: 5 of 175
  • Infectious Diseases 1.5k
  • Pharmacology 322
  • Neurology 555
  • Ophthalmology 177
  • Analytical Chemistry 177
Replace Miao Zhang with:
Miao Zhang China
Henning Bundgaard Denmark
Angelo Zinellu Italy
Ming Yang China
Katharina Rentsch Switzerland
Weiguo Dong China
Awadhesh Kumar Singh India
Chandra Prakash United States
Zhixiang Wang China
Mark A. Perazella United States
Dongyang Liu relative to Miao Zhang China Miao Zhang's profile →
Citations per field
00.5×6.3×
Miao Zhang · 1×
Citations per year

Countries citing papers authored by Dongyang Liu

Since Specialization
Citations

This map shows the geographic impact of Dongyang Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dongyang Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dongyang Liu more than expected).

Fields of papers citing papers by Dongyang Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dongyang Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dongyang Liu. The network helps show where Dongyang Liu may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Dongyang Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Dongyang Liu Line = papers co-authored together Dongyang Liu links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20250
3 20250
4 20251
5 20250
6 20240
7 20242
8 20242
9 20242
10 20240
11 20240
12 20243
13 20242
14 20244
15 20240
16 20238
17 20228
18 20214
19 202018
20 20193

About Dongyang Liu

Dongyang Liu is a scholar working on Pharmacology, Oncology and Endocrinology, Diabetes and Metabolism, having authored 183 papers that have together received 3.9k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (18 papers), Diabetes Treatment and Management (16 papers), Drug Transport and Resistance Mechanisms (16 papers), Analytical Methods in Pharmaceuticals (10 papers), Antibiotics Pharmacokinetics and Efficacy (10 papers), Lung Cancer Treatments and Mutations (9 papers), Pancreatic function and diabetes (9 papers) and Zeolite Catalysis and Synthesis (8 papers). The work is most often cited by research in Infectious Diseases (1.5k citations), Pharmacology (322 citations) and Neurology (555 citations). Dongyang Liu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Xueting Yao, Haiyan Li, Cheng Cui, Chunli Song, Miao Zhang, Erdan Dong, Fei Ye, Wenjie Tan, Baoying Huang and Li Zhao. Their work appears in journals such as Frontiers in Pharmacology, European Journal of Pharmaceutical Sciences, Clinical Pharmacokinetics, Clinical Pharmacology & Therapeutics and Journal of Chromatography B.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026